Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04595565 |
| Title | Sacituzumab Govitecan in Primary HER2-negative Breast Cancer (SASCIA) |
| Acronym | SASCIA |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | German Breast Group |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | IRL | FRA | ESP | DEU | CHE | BEL | AUT |